Analyst Ranking
Bottom 6%
#4626 out of 4870 analysts
Average Return
-22.42%
Win Rate
24%11 out of 46
Risk vs Reward
Poor
Good

Thomas Shrader's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Annexon IncANNX
+136.19%$2.10$4.96
2023-05-25 -
2024-05-24
Strong Buy
Inmune Bio IncINMB
+117.73%$10.38$22.60
2020-09-01 -
2021-08-30
Strong Buy
Biohaven LtdBHVN
+101.08%$16.74$33.66
2022-12-02 -
2023-12-01
Strong Buy
Coya Therapeutics IncCOYA
+55.34%$5.62$8.73
2023-05-18 -
2024-05-17
Strong Buy
Geron CorpGERN
+54.29%$1.05$1.62
2020-04-03 -
2021-04-01
Strong Buy

Thomas Shrader Analyst Color

Get additional color on Thomas Shrader's coverage of popular stocks

Thomas Shrader's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Aldeyra Therapeutics IncALDX
1Strong Buy$9.00+232.10%Maintains
a month ago
Ovid Therapeutics IncOVID
3Strong Buy$4.00+1,169.84%Maintains
a month ago
Vaxcyte IncPCVX
5Strong Buy$160.00+354.03%Reiterates
2 months ago
Arcturus Therapeutics Holdings IncARCT
1Strong Buy$41.00+228.00%Initiates Coverage On
3 months ago
Alector IncALEC
2Strong Buy$5.00+309.84%Maintains
5 months ago
Ac Immune SaACIU
1Strong Buy$8.00+379.04%Initiates Coverage On
a year ago
Promis Neurosciences IncPMN
1Strong Buy$8.00N/AInitiates Coverage On
2 years ago
Precision Biosciences IncDTIL
1Strong Buy$60.00N/AMaintains
2 years ago
Annexon IncANNX
2Strong Buy$7.00N/AMaintains
2 years ago
Coya Therapeutics IncCOYA
1Strong Buy$15.00N/AInitiates Coverage On
2 years ago
Athira Pharma IncATHA
2Strong Buy$10.00N/AMaintains
2 years ago
Bioatla IncBCAB
3Strong Buy$13.00N/AMaintains
2 years ago
Verona Pharma PLCVRNA
3Strong Buy$31.00N/AMaintains
2 years ago
Biohaven LtdBHVN
1Strong Buy$24.00N/AInitiates Coverage On
2 years ago
Gain Therapeutics IncGANX
2Strong Buy$10.00N/AMaintains
2 years ago
Sqz Biotechnologies CoSQZB
2Strong Buy$15.00N/AMaintains
3 years ago
Acumen Pharmaceuticals IncABOS
2Strong Buy$22.00N/AMaintains
3 years ago
Inmune Bio IncINMB
2Strong Buy$14.00N/AMaintains
3 years ago
Sigilon Therapeutics IncSGTX
1Strong Buy$182.00N/AInitiates Coverage On
4 years ago
Pliant Therapeutics IncPLRX
1Strong Buy$51.00N/AInitiates Coverage On
4 years ago
Celularity IncCELU
1Strong Buy$16.00N/AInitiates Coverage On
4 years ago
Oncosec Medical IncONCSQ
1Strong Buy$220.00N/AInitiates Coverage On
4 years ago
Nuvation Bio IncNUVB
1Strong Buy$16.00N/AInitiates Coverage On
4 years ago
Voyager Therapeutics IncVYGR
1HoldN/AN/ADowngrades
4 years ago
Eidos Therapeutics IncEIDX
1HoldN/AN/ADowngrades
4 years ago
Denali Therapeutics IncDNLI
1HoldN/AN/ADowngrades
5 years ago
89bio IncETNB
1Strong Buy$58.00N/AMaintains
5 years ago
Checkmate Pharmaceuticals IncCMPI
1Strong Buy$29.00N/AInitiates Coverage On
5 years ago
Geron CorpGERN
1Strong Buy$3.00N/AMaintains
5 years ago
Acorda Therapeutics IncACORQ
1Hold$840.00N/AMaintains
6 years ago
Biogen IncBIIB
3Hold$346.00N/ADowngrades
6 years ago
Momenta Pharmaceuticals IncMNTA
2Strong BuyN/AN/AUpgrades
7 years ago
Kite Pharma IncKITE
1HoldN/AN/ADowngrades
8 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.